Advertisement

Molecular Biology Reports

, Volume 38, Issue 5, pp 2911–2918 | Cite as

Associations between GSTM1 and OGG1 Ser326Cys polymorphisms and smoking on chromosomal damage and birth growth in mothers

  • Bensu KarahalilEmail author
  • Esra Emerce
  • Neslihan Aygün Kocabaş
  • Elif Akkaş
Article

Abstract

The presenting study was investigated the associations between individual susceptibility and cigarette smoke on maternal chromosomal damage and neonatal birth growth in smoking mothers since little known about genetic susceptibility to cigarette smoke in relation to adverse pregnancy outcome such as birth growth. Sixty-one pregnant women who completed a questionnaire at Ankara Education and Research Hospital, Department of Obstetrics and Gynecology have enrolled in this study. GSTM1 and OGG1 ser326Cys gene polymorphisms were analysed by RFLP-PCR (Restriction Fragment Length Polymorphism-Polymerase Chain Reaction) as possible genetic factors affecting susceptibility to such health effects of smoking and chromosomal damage was performed by chromosomal aberration assay (CAA) in maternal blood lymphocytes. Maternal self-reported history of pregnancy smoking was informed by questionnaire declaration. Our results showed that maternal smoking had significant effect on chromosomal damage, birth weight, and length. The frequencies of CA in smokers was significantly higher than that of the nonsmokers (3.46 ± 2.06 and 2.00 ± 1.3, P = 0.001). Birth weight and length in smokers were significantly higher that of nonsmokers (3,355 g and 49.57 cm, P = 0.001; 3,639 g and 50.79 cm, P = 0.002). On the other hand, there was a slightly increased in the frequencies of CA and reduction birth weight and length in GSTM1 null and length in OGG1 variant genotypes, those differences were not statistically significant (P > 0.05); likely due to small sample size. Larger sample size needs to reach significance.

Keywords

Maternal smoking Birth weight Birth length GSTM1 OGG1 Ser326Cys Chromosomal aberrations 

Notes

Acknowledgments

Experiments carried out in the present study comply with the current laws of the country in which the experiments were performed. The authors would like to give special thanks to all participants. We wish also thank to Assoc. Prof. Kenan Özköse for statistical analysis.

References

  1. 1.
    Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, Niu T, Wise PH, Bauchner H, Xu X (2002) Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 287:195–202PubMedCrossRefGoogle Scholar
  2. 2.
    Wu FY, Wu HD, Yang HL, Kuo HW, Ying JC, Lin CJ, Yang CC, Lin LY, Chiu TH, Lai JS (2007) Associations among genetic susceptibility, DNA damage, and pregnancy outcomes of expectant mothers exposed to environmental tobacco smoke. Sci Total Environ 386:124–133PubMedCrossRefGoogle Scholar
  3. 3.
    Delpisheh A, Brabin L, Topping J, Reyad M, Tang AW, Brabin BJ (2009) A case-control study of CYP1A1, GSTT1 and GSTM1 gene polymorphisms, pregnancy smoking and fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 143:38–42PubMedCrossRefGoogle Scholar
  4. 4.
    DeMarini DM (2004) Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 567:447–474PubMedCrossRefGoogle Scholar
  5. 5.
    Tabacova S, Baird DD, Balabaeva L (1998) Exposure to oxidized nitrogen: lipid peroxidation and neonatal health risk. Arch Environ Health 53:214–221PubMedCrossRefGoogle Scholar
  6. 6.
    Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguez H (2002) Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 32:1102–1115PubMedCrossRefGoogle Scholar
  7. 7.
    Wan J, Winn LM (2006) In utero-initiated cancer: the role of reactive oxygen species. Birth Defects Res (Part C) 78:326–332CrossRefGoogle Scholar
  8. 8.
    Qanungo S, Murherjea M (2000) Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues. Mol Cell Biochem 215:11–19PubMedCrossRefGoogle Scholar
  9. 9.
    Anderson LM (2006) Environmental genotoxicants/carcinogens and childhood cancer: bridgeable gaps in scientific knowledge. Mutat Res 608:136–156PubMedGoogle Scholar
  10. 10.
    Chang JS (2009) Parental smoking and childhood leukemia. Methods Mol Biol 472:103–137PubMedCrossRefGoogle Scholar
  11. 11.
    Stucker I, de Waziers I, Cenee S, Bignon J, Depierre A, Milleron B, Beaune P, Hemon D (1999) GSTM1, smoking and lung cancer: a case-control study. Int J Epidemiol 28:829–835PubMedCrossRefGoogle Scholar
  12. 12.
    Hong YC, Lee KH, Son BK, Ha EH, Moon HS, Ha M (2003) Effects of the GSTM1 and GSTT1 polymorphisms on the relationship between maternal exposure to environmental tobacco smoke and neonatal birth weight. J Occup Environ Med 45:492–498PubMedCrossRefGoogle Scholar
  13. 13.
    Kocabas NA, Karahalil B, Karakaya AE, Sardas S (2000) Influence of GSTM1 genotype on comet assay and chromosome aberrations after induction by bleomycin in cultured human lymphocytes. Mutat Res 469:199–205PubMedGoogle Scholar
  14. 14.
    Karahalil B, Emerce E, Koçer B, Han S, Alkiş N, Karakaya AE (2008) The association of OGG1 Ser326Cys polymorphism and urinary 8-OHdG levels with lung cancer susceptibility: a hospital-based case-control study in Turkey. Arh Hig Rada Toksikol 59:241–250PubMedGoogle Scholar
  15. 15.
    Smart DJ, Chipman JK, Hodges NJ (2006) Activity of OGG1 variants in the repair of pro-oxidant-induced 8-oxo-2′-deoxyguanosine. DNA Repair (Amst) 5:1337–1345CrossRefGoogle Scholar
  16. 16.
    Stuart JA, Karahalil B, Hogue BA, Souza-Pinto NC, Bohr VA (2004) Mitochondrial and nuclear DNA base excision repair are affected differently by caloric restriction. FASEB J 18:595–597PubMedGoogle Scholar
  17. 17.
    Radaka Z, Gotob S, Nakamotob H, Ududc K, Papaic Z, Horvathc I (2005) Lung cancer in smoking patients inversely alters the activity of hOGG1 and hNTH1. Cancer Lett 219:191–195CrossRefGoogle Scholar
  18. 18.
    Au WW, Cajas-Salazar N, Salama S (1998) Factors contributing to discrepancies in population monitoring studies. Mutat Res 400:467–478PubMedGoogle Scholar
  19. 19.
    Karahalil B, Yağar S, Bahadir G, Durak P, Sardaş S (2005) Diazepam and propofol used as anesthetics during open-heart surgery do not cause chromosomal aberrations in peripheral blood lymphocyte. Mutat Res 581:181–186PubMedGoogle Scholar
  20. 20.
    Windham GC, Hopkins B, Fenster L, Swan SH (2000) Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology 11:427–433PubMedCrossRefGoogle Scholar
  21. 21.
    Ellard GA, Johnstone FD, Prescott RJ, Ji-Xian PW, Jian-Hua M (1996) Smoking during pregnancy: the dose dependence of birthweight deficits. Int J Obstet Gynecol 103:806–813Google Scholar
  22. 22.
    Ohmi H, Hirooka K, Mochizuki Y (2002) Fetal growth and the timing of exposure to maternal smoking. Pediatr Int 44:55–59PubMedCrossRefGoogle Scholar
  23. 23.
    Hartsfield JK Jr, Hickman TA, Everett ET, Shaw GM, Lammer EJ, Finnell RA (2001) Analysis of the EPHX1 113 polymorphism and GSTM1 homozygous null polymorphism and oral clefting associated with maternal smoking. An J Med Genet 102:21–24CrossRefGoogle Scholar
  24. 24.
    Masetti S, Botto N, Manfredi S, Colombo MG, Rizza A, Vassalle C, Clerico A, Biagini A, Andreassi MG (2003) Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med 81:488–494PubMedCrossRefGoogle Scholar
  25. 25.
    Sasaki S, Kondo T, Sata F, Saijo Y, Katoh S, Nakajima S, Ishizuka M, Fujita S, Kishi R (2006) Maternal smoking during pregnancy and genetic polymorphisms in the Ah receptor, CYP1A1 and GSTM1 affect infant birth size in Japanese subjects. Mol Hum Reprod 12:77–83PubMedCrossRefGoogle Scholar
  26. 26.
    Asami S, Manabe H, Miyake J, Tsurudome Y, Hirano T, Yamaguchi R, Kasai R, Itoh H (1997) Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxyguanosin, in a central site of the human lung. Carcinogenesis 18:1763–1766PubMedCrossRefGoogle Scholar
  27. 27.
    Karahalil B, Kocabas NA, Ozcelik T (2006) DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population. Anticancer Res 26(6C):4955–4958PubMedGoogle Scholar
  28. 28.
    Blake KV, Gurrin LC, Evans SF, Beilin LJ, Landau LI, Stanley FJ, Newnham JP (2000) Maternal cigarette smoking during pregnancy, low birth weight and subsequent blood pressure in early childhood. Early Hum Dev 57:137–147PubMedCrossRefGoogle Scholar
  29. 29.
    Wills RA, Coory MD (2008) Effect of smoking among indigenous and non-indigenous mothers on preterm birth and full-term low birthweight. Med J Aust 189:490–494PubMedGoogle Scholar
  30. 30.
    Nijiati K, Satoh K, Otani K, Kimata Y, Ohtaki M (2008) Regression analysis of maternal smoking effect on birth weight. Hiroshima J Med Sci 57:61–67PubMedGoogle Scholar
  31. 31.
    Barker DJP (1998) In utero programming of chronic disease. Clin Sci 95:115–128PubMedCrossRefGoogle Scholar
  32. 32.
    Tsai HJ, Liu X, Mestan K, Yu Y, Zhang S, Fang Y, Pearson C, Ortiz K, Zuckerman B, Bauchner H, Cerda S, StubbleWeld PG, Xu X, Wang X (2008) Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on G£E interactions and pathogenic pathways. Hum Genet 123:359–369PubMedCrossRefGoogle Scholar
  33. 33.
    Gloria-Bottini F, Magrini A, Pietropolli A, Bergamaschi A, Bottini E (2009) Smoking and human reproduction: the effect of adenylate kinase genetic polymorphism. Am J Perinatol 26:117–121PubMedCrossRefGoogle Scholar
  34. 34.
    Ramsey MJ, More DH II, Briner JF, Lee DA, Olsen L, Senft JR, Tucker JD (1995) The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mutat Res 338:95–106PubMedGoogle Scholar
  35. 35.
    Pluth JM, Ramsey MJ, Tucker JD (2000) Role of maternal exposures and newborn genotypes on newborn chromosome aberration frequencies. Mutat Res 465:101–111PubMedGoogle Scholar
  36. 36.
    Perera FP, Tang D, Tu YH, Cruz LA, Borjas M, Bernert T, Whyatt RM (2004) Biomarkers in maternal and newborn blood indicate heightened fetal susceptibility to procarcinogenic DNA damage. Environ Health Perspect 112:1133–1136PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Bensu Karahalil
    • 1
    Email author
  • Esra Emerce
    • 1
  • Neslihan Aygün Kocabaş
    • 1
  • Elif Akkaş
    • 2
  1. 1.Department of Toxicology, Faculty of PharmacyGazi UniversityAnkaraTurkey
  2. 2.Clinics of Gynecology and Obstetrics, Ankara HospitalAnkaraTurkey

Personalised recommendations